After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.
New perspective calls for dynamic, multidimensional stratification systems to address patient heterogeneity that is overlooked by standardized protocols.